# Insulin medicines: Bill of materials

Source page: https://www.materialinsights.org/products/p_insulin_medicines/prod-bom/

#### About these figures

Which unit, study and year the composition figures describe, and how they vary

No source opened gives the make-up of a vial or pen in grams. The active ingredient is a peptide made by microbes ^[6]. The medicine is sold as a solution or suspension in vials and cartridges ^[7] or in plastic pre-filled pens with glass inside ^[16]; no source opened lists the other ingredients. The pen body and the glass container are not yet product nodes. Stages are named only; no process conditions, strains or recipes are given.

as of 2026-11-13

#### Direct materials

The commodities and chemicals in one unit as bought, with amount, mass share, cost share and recycled content

| Material | Role | Amount in one unit | Share of the unit's mass |
|---|---|---|---|
| [Pep Peptides and oligonucleotides](https://www.materialinsights.org/chemicals/peptides_oligos/) | Functional | Not given | – |
| The active ingredient, insulin, is a peptide made recombinantly by microbes ^[6]; no source opened gives the mass per vial or pen. |  |  |  |

as of 2026-11-13

#### How it is put together

The main steps from parts and materials to the finished unit

| Step | What happens | Technology | Source |
|---|---|---|---|
| Recombinant production | Yeast, or E. coli in the bacterial route, carrying the human gene make an insulin precursor | Recombinant DNA (genetic engineering) | ^[6] |
| Conversion | An enzyme turns the precursor into human insulin; the E. coli route has an extra refolding stage | – | ^[6] |
| Chemical modification | For some analogues a fatty acid is attached to the insulin | – | ^[6] |
| Formulation and filling | The insulin is formulated and filled into cartridges and pre-filled pens, or into vials | – | ^[17]^[7] |

as of 2026-11-13

#### Technologies used to make it

The technologies used to make it, at which step
 Made with

- [rDNA Recombinant DNA (genetic engineering)](https://www.materialinsights.org/technologies/recombinant_dna/) Recombinant production of the insulin precursor Humulin, approved by the FDA in 1982, was made by bacteria and was the first FDA-approved recombinant drug of any kind ^[3]; no share of output made this way was found.

as of 2026-11-13

#### Sources

1. [Insulin Development and Commercialization](https://www.Acs.Org/content/dam/acsorg/education/whatischemistry/landmarks/insulin/insulin-booklet.pdf) American Chemical Society (National Historic Chemical Landmark), 2023, landmark booklet, © 2023 American Chemical Society
2. [Insulin: Recombinant Production, Sustainability, and Chemistry](https://oxfordglobal.com/biologics/resources/insulin-recombinant-production-sustainability-and-chemistry) Oxford Global (article by Tom Cohen on a presentation by Thomas Høeg-Jensen, Scientific Director at Novo Nordisk), 2023, page of 25 April 2023
3. [First human insulins prequalified](https://extranet.who.int/pqweb/news/first-human-insulins-prequalified) World Health Organization, Prequalification of Medical Products, 2022, news item of 28 September 2022
4. [Patients return 200,000 injection pens through recycling scheme](https://pharmaceutical-journal.com/article/news/patients-return-200000-injection-pens-through-recycling-scheme) The Pharmaceutical Journal (David Lipanovic), 2023, article of 15 August 2023
5. [Novo Nordisk Opens New Insulin Formulation and Filling Facility in Russia](https://www.cphi-online.com/news/novo-nordisk-opens-new-insulin-formulation-and-filling-facility-in-russia/) CPHI Online, 2015, news item of 16 April 2015

## Other sections

- [Summary](https://www.materialinsights.org/products/p_insulin_medicines/index.md)
- [Working](https://www.materialinsights.org/products/p_insulin_medicines/prod-working/index.md)
- [Use case](https://www.materialinsights.org/products/p_insulin_medicines/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_insulin_medicines/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_insulin_medicines/prod-footprint/index.md)
- [Evolution](https://www.materialinsights.org/products/p_insulin_medicines/prod-evolution/index.md)
- [Interventions](https://www.materialinsights.org/products/p_insulin_medicines/prod-interventions/index.md)
